DCN Dx Acquires Biomed Diagnostics
April 25, 2022
DCN Dx, a provider of point-of-use test development and commercialization, completed its acquisition of Biomed Diagnostics, a microbiological testing products company based in White City, Oregon. The deal expands DCN Dx’s footprint in point-of-use testing and sampling across both human and veterinary verticals.
- Buyers
- DCN Dx
- Targets
- Biomed Diagnostics, Inc.
- Sellers
- Liberty Ridge Advisors
- Industry
- Healthcare Services
- Location
- Oregon, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.